Results 231 to 240 of about 3,015,402 (387)

Consideration of ethnic differences in approvals for anti‐HIV medicines in Japan: Evaluation based on pharmacokinetic studies and post‐marketing data

British Journal of Clinical Pharmacology, EarlyView.
More than 30 anti‐HIV drugs have been approved in Japan using data from dossiers submitted to the United States or European regulatory authorities since 1998. These drugs were approved with the same dosage and administration regimes as in the United States and Europe, using data from pivotal studies that rarely included any Japanese patients, whereas ...
Rumiko Shimazawa, Masayuki Ikeda
wiley   +1 more source

Marking the HIV hideout [PDF]

Nature Reviews Immunology, 2017
openaire   +3 more sources

Adverse childhood experiences and disengagement from HIV care: a case-cohort study in Tanzania. [PDF]

AIDS Res Ther
Tucker S, Winters S, Katabaro E, Mlowe M, Bradshaw P, Ahern J, Colford J, Packel L, Hillis S, Sabasaba A, Njau P, McCoy SI.   +11 more
europepmc   +1 more source

Amiloidose Renal em Paciente Portadora de HIV: Relato de Caso/ Renal Amyloidosis in a Patient with HIV: Case Report

, 1970
Daiana Knopp Barbosa, Deborah Rodrigues Matteucci, Pablo Girardelli Mendonça Mesquita   +2 more
openalex   +2 more sources

Refusal to treat AIDS and HIV positive patients. [PDF]

, 1987
R Gillon
openalex   +1 more source

Approaches to repurposing reverse transcriptase antivirals in cancer

British Journal of Clinical Pharmacology, EarlyView.
This review highlights the role of reverse transcriptase (RT) inhibition in cellular regulation associated with non‐terminal repeat retrotransposons and endogenous retroviruses. Based on their pleiotropic characteristics, RT inhibitors (RTIs) are discussed as potential anticancer agents.
Richard Head, Saiful Islam, Jennifer H. Martin   +2 more
wiley   +1 more source

Angiotensin II Type 1 Receptor Blocker Usage Prevents Oxidative Stress and Muscle Dysfunction in HIV. [PDF]

Fundam Clin Pharmacol
Deminice R, Cella PS, Borsari AL, Padilha CS, de Oliveira VHF.   +4 more
europepmc   +1 more source

Progressive neurological dysfunction during latent HIV infection. [PDF]

, 1989
Janus Christian Jakobsen, Shad B. Smith, Janne E. Gaub, S. Helweg‐Larsen, W. Trojaborg   +4 more
openalex   +1 more source

Electronic medicine management systems in developing countries: A landscape review

British Journal of Clinical Pharmacology, EarlyView.
Medicines are a major global health expense. However, suboptimal use increases costs and causes patient harm. One way to reduce costs and increase safe, efficient medicines use is with electronic medicines management systems (EMMS). They allow easy capture of routine health data which can facilitate research, service planning and reimbursement ...
Andrew Lambarth, Dalia Wainwright, Trisha Saha, Millicent Banks, Iona Minty, P.A.M.K. Abeywickrama, Reya V. Shah, Yogini Jani, Reecha Sofat   +8 more
wiley   +1 more source

Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C. [PDF]

Viruses
Venkatachalam S, Muralidharan N, Pandian R, Sayed Y, Gromiha MM.   +4 more
europepmc   +1 more source